Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas
Open Access
- 19 April 2013
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 26 (10) , 1401-1412
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Performance of PREMM1,2,6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesGenetics in Medicine, 2012
- Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencingLaboratory Investigation, 2012
- Identification of Cancer Patients with Lynch Syndrome: Clinically Significant Discordances and Problems in Tissue-Based Mismatch Repair TestingCancer Prevention Research, 2012
- Pathologic Scoring of PTEN Immunohistochemistry in Endometrial Carcinoma is Highly ReproducibleInternational Journal of Gynecological Pathology, 2012
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein StabilityCancer Discovery, 2011
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial CarcinomasClinical Cancer Research, 2011
- Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinomaJournal of Clinical Pathology, 2009
- Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch SyndromeJournal of Clinical Oncology, 2008
- Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆Gynecologic Oncology, 2007
- RAS/RAF mutation and defective DNA mismatch repair in endometrial cancersAmerican Journal of Obstetrics and Gynecology, 2004